Pioglitazone
Showing 1 - 25 of 616
ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),
Not yet recruiting
- ANCA Associated Vasculitis
- +2 more
- Pioglitazone (ACTOS®)
- Placebo of Pioglitazone
- (no location specified)
Jul 7, 2023
Myocardial Reperfusion Injury Trial in Campinas (Pioglitazone 45 mg, Placebo)
Not yet recruiting
- Myocardial Reperfusion Injury
- Pioglitazone 45 mg
- Placebo
-
Campinas, SP, BrazilUniversity of Campinas
Mar 17, 2023
Calcification of Aortic Valve, Aortic Valve Stenosis Trial (Drug: Pioglitazone Oral Tablet, Placebo)
Not yet recruiting
- Calcification of Aortic Valve
- Aortic Valve Stenosis
- Drug: Pioglitazone Oral Tablet
- Placebo
- (no location specified)
May 24, 2023
Oral Leukoplakia Trial in Minneapolis (pioglitazone-metformin)
Not yet recruiting
- Oral Leukoplakia
-
Minneapolis, MinnesotaUniversity of Minnesota
Feb 4, 2023
Lung Cancer Trial in Baton Rouge (Pioglitazone 45 mg, Placebo)
Not yet recruiting
- Lung Cancer
- Pioglitazone 45 mg
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jun 22, 2023
Type 2 Diabetes in Obese, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Pioglitazone, Placebo)
Not yet recruiting
- Type 2 Diabetes Mellitus in Obese
- Heart Failure With Preserved Ejection Fraction
- Pioglitazone
- Placebo
-
San Antonio, TexasTexas Diabetes Institute/UH
Apr 20, 2023
Non-Alcoholic Fatty Liver Disease, Type2diabetes Trial in Karachi (Empagliflozin 10 MG, Pioglitazone 15mg, Metformin)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Type2diabetes
- Empagliflozin 10 MG
- +2 more
-
Karachi, Sindh, PakistanMedical ICU, Jinnah Postgraduate Medical Centre
Jul 11, 2023
Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg
Not yet recruiting
- Type2diabetes
- Insulin Resistance
- Metformin
- +2 more
- (no location specified)
Oct 20, 2022
Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Pioglitazone
-
Haifa, IsraelRambam Health Care Campus
Feb 22, 2023
Intracerebral Haemorrhage, Intraventricular Trial (Pioglitazone 15mg)
Not yet recruiting
- Intracerebral Haemorrhage, Intraventricular
- Pioglitazone 15mg
- (no location specified)
Dec 9, 2022
Breast Cancer, Muscle Fatigue Trial in Morgantown (Pioglitazone 15mg, Pioglitazone 30 mg)
Recruiting
- Breast Cancer
- Muscle Fatigue
- Pioglitazone 15mg
- Pioglitazone 30 mg
-
Morgantown, West VirginiaWest Virginia University Cancer Institute
Jul 11, 2022
Type 2 Diabetes, Blood Glucose Fluctuation Trial in Nanjing (Metformin plus pioglitazone, Acarbose)
Recruiting
- Type 2 Diabetes
- Blood Glucose Fluctuation
- Metformin plus pioglitazone
- Acarbose
-
Nanjing, ChinaNanjing First Hospital, Nanjing Medical Univesity
Nov 28, 2022
Alcohol Use Disorder Trial in Houston (Pioglitazone, Placebo)
Recruiting
- Alcohol Use Disorder
- Pioglitazone
- Placebo
-
Houston, TexasThe University of Texas Health Science Center of Houston
Aug 29, 2022
Diabetes Type 2 With Hyperglycemia Trial in Los Angeles (Hydroxychloroquine, Pioglitazone)
Terminated
- Diabetes Mellitus Type 2 With Hyperglycemia
- Hydroxychloroquine
- Pioglitazone
-
Los Angeles, CaliforniaCharles Drew University of Medicine and Science
Sep 23, 2022
Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)
Recruiting
- Prostate Cancer
- +3 more
- Pioglitazone 30 mg
- Placebo
-
Buffalo, New YorkDiabetes and Endocrinology Research Center of WNY
Oct 26, 2022
Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)
Not yet recruiting
- Non Alcoholic Steatohepatitis
- Pioglitazone 30mg
- Empagliflozin 10 MG
-
Tanta, Gharbiya, EgyptTanta University
Nov 2, 2022
Type2 Diabetes Trial in Seoul (Metformin=1000mg, Pioglitazone 15mg, Pioglitazone 30 mg)
Active, not recruiting
- Type2 Diabetes
- Metformin≥1000mg
- +5 more
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 12, 2022
Cocaine Use Disorder Trial in Houston (Cognitive Behavioral Therapy (CBT), Pioglitazone, Placebo)
Recruiting
- Cocaine Use Disorder
- Cognitive Behavioral Therapy (CBT)
- +2 more
-
Houston, TexasUTHealth Center for Neurobehavioral Research on Addiction
Jun 7, 2022
Chronic Kidney Diseases Trial in Arlington, Dallas (Pioglitazone, Placebo)
Recruiting
- Chronic Kidney Diseases
- Pioglitazone
- Placebo
-
Arlington, Texas
- +1 more
May 24, 2022
Gastroparesis Trial in Baltimore (Pioglitazone 30 mg)
Recruiting
- Gastroparesis
- Pioglitazone 30 mg
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Mar 8, 2022
Head Neck Cancer, Oral Leukoplakia Trial in Minneapolis (pioglitazone HCl)
Completed
- Head and Neck Cancer
- Oral Leukoplakia
- pioglitazone hydrochloride
-
Minneapolis, MinnesotaUniversity of Minnesota Medical Center-Fairview
Jan 13, 2022
Bladder Cancer in Type 2 Diabetes Pioglitazone Therapy "PROBE"
Completed
- Bladder Cancer
- Pioglitazone
-
Chandigarh, IndiaDeptt of Endocrinology
Jan 23, 2022
Type 2 Diabetes Trial in Stockholm (Pioglitazone 45 mg, Empagliflozin 25 MG, Semaglutide 7 MG)
Not yet recruiting
- Type 2 Diabetes
- Pioglitazone 45 mg
- +2 more
-
Stockholm, SwedenKarolinska University Hospital
Aug 11, 2022
Inflammation Trial in Buffalo (Pioglitazone 15mg, pioglitazone 30mg, )
Completed
- Inflammation
- Pioglitazone 15mg
- +2 more
-
Buffalo, New YorkMillard Fillmore gates Hospital
Jan 12, 2022
Hepatitis B, Chronic, Fibrosis, Liver, Diabetes, Type 2 Trial in Seoul (Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg)
Active, not recruiting
- Hepatitis B, Chronic
- +2 more
- Pioglitazone 15 Mg Oral Tablet
- Evogliptin 5mg
-
Seoul, Korea, Republic of
- +3 more
Jul 21, 2022